Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-085387
Filing Date
2026-08-05
Accepted
2026-08-05 07:00:01
Documents
2
Period of Report
2026-08-05

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0300584-6k_kamada.htm 6-K 10973
2 KAMADA TO ANNOUNCE SECOND QUARTER AND FIRST HALF ENDED JUNE 30, 2026 FINANCIAL R ea030058401ex99-1.htm EX-99.1 6175
  Complete submission text file 0001213900-26-085387.txt   18167
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Filer) CIK: 0001567529 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35948 | Film No.: 261241251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)